CN116076637A - 一种可调理情绪的药食同源饮品 - Google Patents
一种可调理情绪的药食同源饮品 Download PDFInfo
- Publication number
- CN116076637A CN116076637A CN202211132799.0A CN202211132799A CN116076637A CN 116076637 A CN116076637 A CN 116076637A CN 202211132799 A CN202211132799 A CN 202211132799A CN 116076637 A CN116076637 A CN 116076637A
- Authority
- CN
- China
- Prior art keywords
- parts
- drink
- fructus aurantii
- weight
- conditioning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 230000008451 emotion Effects 0.000 title claims abstract description 16
- 235000013305 food Nutrition 0.000 title claims abstract description 15
- 229940079593 drug Drugs 0.000 title description 14
- 230000001105 regulatory effect Effects 0.000 title description 3
- 239000002994 raw material Substances 0.000 claims abstract description 34
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 28
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 24
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 19
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 19
- 241000237502 Ostreidae Species 0.000 claims abstract description 19
- 235000020636 oyster Nutrition 0.000 claims abstract description 19
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 18
- 235000011477 liquorice Nutrition 0.000 claims abstract description 18
- 239000010135 fructus aurantii immaturus Substances 0.000 claims abstract description 17
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 16
- 230000003750 conditioning effect Effects 0.000 claims abstract description 10
- 244000183685 Citrus aurantium Species 0.000 claims description 23
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 210000000988 bone and bone Anatomy 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 210000004185 liver Anatomy 0.000 abstract description 20
- 208000024891 symptom Diseases 0.000 abstract description 19
- 210000002784 stomach Anatomy 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 11
- 206010003591 Ataxia Diseases 0.000 abstract description 6
- 206010010947 Coordination abnormal Diseases 0.000 abstract description 6
- 208000016290 incoordination Diseases 0.000 abstract description 6
- 230000002996 emotional effect Effects 0.000 abstract description 4
- 206010061245 Internal injury Diseases 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 description 27
- 230000036506 anxiety Effects 0.000 description 27
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 15
- 206010022437 insomnia Diseases 0.000 description 15
- 238000000034 method Methods 0.000 description 10
- 235000013361 beverage Nutrition 0.000 description 9
- 230000001976 improved effect Effects 0.000 description 9
- 208000001431 Psychomotor Agitation Diseases 0.000 description 8
- 206010038743 Restlessness Diseases 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 206010013954 Dysphoria Diseases 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 206010022998 Irritability Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 5
- 206010067171 Regurgitation Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- BGRJTUBHPOOWDU-NSHDSACASA-N (S)-(-)-sulpiride Chemical compound CCN1CCC[C@H]1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-NSHDSACASA-N 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 208000009205 Tinnitus Diseases 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000003340 mental effect Effects 0.000 description 4
- 230000036565 night sweats Effects 0.000 description 4
- 206010029410 night sweats Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 229960004940 sulpiride Drugs 0.000 description 4
- 231100000886 tinnitus Toxicity 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 208000020401 Depressive disease Diseases 0.000 description 3
- 208000007443 Neurasthenia Diseases 0.000 description 3
- 206010029333 Neurosis Diseases 0.000 description 3
- 206010029412 Nightmare Diseases 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 3
- 229960003120 clonazepam Drugs 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 208000015238 neurotic disease Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010012374 Depressed mood Diseases 0.000 description 2
- 206010015137 Eructation Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 208000027687 belching Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 208000023652 chronic gastritis Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229960004391 lorazepam Drugs 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 208000000689 peptic esophagitis Diseases 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 description 1
- 206010002869 Anxiety symptoms Diseases 0.000 description 1
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010041243 Social avoidant behaviour Diseases 0.000 description 1
- 208000033042 Somatoform disorder cardiovascular Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000013200 Stress disease Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000010006 flight Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 208000037870 generalized anxiety Diseases 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000020796 long term synaptic depression Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000009157 neurocirculatory asthenia Diseases 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Anesthesiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种可调理情绪的药食同源饮品,所述饮品按重量份计包括以下原料:栀子1‑20份、新会陈皮1‑5份、广陈皮1‑15份、青皮1‑15份、枳壳1‑20份、枳实1‑10份、甘草1‑20份和牡蛎1‑50份。本发明的饮品以栀子、甘草、橘皮类和牡蛎等中药为主要成分,药食同源,组方逻辑清晰,对肝胃不和、情志内伤和心肾不交导致的诸多症状都有明显疗效。
Description
技术领域
本发明涉及中药技术应用领域,具体涉及一种有针对性的调理情绪的药食同源的饮品。
背景技术
由于城市化进程和环境饮食等方面的变化,现代都市人群由于工作压力、物质丰富引起的饮食富营养、环境等方面的影响,普遍存在亚健康的问题,一般都表现为体检未见明显异常者,西药又无适应症状的不适感。
并且,焦虑是人群在与环境作斗争及生存适应的过程中发展起来的基本人类情绪,适度的焦虑具有积极的意义,它可以充分地调动身体机能,适度提高大脑的反应速度和警觉性。然而,长久的、泛化的和与现实处境明显脱钩的焦虑则会给人们带来过度的压力体验,有相关研究证明,过度焦虑是造成慢性胃炎、反流性食管炎、社交退缩、生活意向下降、影响社会和谐等现象的最主要原因之一。
焦虑也是一个主观程度,几乎人人都有过想摆脱目前现状却无可奈何的感觉。因而对焦虑的处置也因人而异。常人处置焦虑的方法一般会有直面、引导、逃避、宣泄等策略。形式上,则有阅读、听音乐、看电影、放松训练、压力传导-发泄、感官刺激、旅游甚至相当大比例人群刷视频、看直播也是为了对抗焦虑。这些方法通常都是有效的。
然而,不能通过自我调节的焦虑——即,严重心理问题程度(影响工作、社交、生活、学习等)就会触发心理止损机制,寻求外界帮助。常见的形式有:与人深聊倾诉、暴力发泄、反复体检、求医、卜卦、退缩行为、心理咨询等。在国内,在精神心理科就诊是一件自觉有耻感的事情,且焦虑者往往恐惧服药。
焦虑也引发对身体的过分担忧,出现反复求医、检查等,占用且浪费了大量优质的医疗资源。总结来看,焦虑引起的病症反应,最主要的表现集中在以下方面:
·肝胃不和证,见嗳气、胃脘痛、吞酸嘈杂、呆食、抑郁、胃肠功能紊乱等。
·情志内伤证,见焦虑、抑郁、惊恐、易怒、神经衰弱、神经官能症等。
·心肾不交证,见心烦、烦热、失眠、惊悸、梦魇、耳鸣、盗汗等。
因此,对严重焦虑人群的有效管理以及简单有效的症状缓解可以促进人际和谐、节省社会资源并提高生产效能。
发明内容
针对上述问题,本发明提供的饮品产品,广泛适用于例如心理咨询、健康管理、社区健康驿栈、游客服务中心处理接待易激惹游客、大型航班或高铁延误导致旅客焦虑、各种考前焦虑、重大要活动前应激障碍、灾后应急安抚、工会群众工作、中小学生学习焦虑等现代社会所特有的焦虑场景环境中,符合严重焦虑情绪的人群均可应用。
具体的,本发明首先提供一种针对5年病史(含)以内的焦虑、心烦、轻度至中度失眠等问题的人群、或青壮年人群,主要针对年轻的亚健康群体的情绪问题的产品:一种可调理情绪的药食同源饮品,所述饮品按重量份计由以下原料制成:栀子1-20份、新会陈皮1-5份、广陈皮1-15份、青皮1-15份、枳壳1-20份、枳实1-10份、甘草1-20份和牡蛎1-50份。该饮品为基础方。
优选的,所述饮品按重量份计由以下原料制成:栀子3份、新会陈皮1份、广陈皮2份、青皮3份、枳壳2份、枳实1份、甘草5份和牡蛎5份。
其中,所述饮品通过如下方法制备:按重量份比例称取栀子、新会陈皮、广陈皮、青皮、枳壳、枳实、甘草和牡蛎;混合均匀,加入原料总重量的20-30倍重量的水,浸泡30分钟;将浸泡后的混合物大火熬制至沸腾,转小火再煎10分钟;熄火,冷却至室温,即获得所述饮品。针对该基础方,加水量优选为上述原料总重的约30倍重量的水(优选,纯净水)。
该饮品一般规格为200ml每瓶。针对上述目标人群,建议用量为:100-200ml每次,每天2次。最大剂量为:200ml每次,每天3次。
进一步的,针对5年病史以上的焦虑、心烦、重度失眠等问题的人群、尤其是中老年病史长的人群,本发明还提供一种在上述产品基础上的加强方饮品:一种可调理情绪的药食同源饮品,所述饮品按重量份计由以下原料制成:栀子1-20份、新会陈皮1-5份、广陈皮1-15份、青皮1-15份、枳壳1-20份、枳实1-10份、甘草1-20份、牡蛎1-50份、龙骨1-50份、灯心草1-10份、酸枣仁1-30份和柏子仁1-30份。
优选的,所述饮品按重量份计由以下原料制成:栀子3份、新会陈皮1份、广陈皮2份、青皮3份、枳壳2份、枳实1份、甘草7份、灯心草3份、酸枣仁10份、柏子仁10份、龙骨20份和牡蛎20份。
其中,所述饮品通过如下方法制备:按重量份比例称取栀子、新会陈皮、广陈皮、青皮、枳壳、枳实、甘草、灯心草、酸枣仁、柏子仁、龙骨和牡蛎;混合均匀,加入原料总重量的20-30倍重量的水,浸泡30分钟;将浸泡后的混合物大火熬制至沸腾,转小火再煎10分钟;熄火,冷却至室温,即获得所述饮品。针对该加强方,加水量优选为上述原料总重的约20倍重量的水(优选,纯净水)。
该饮品一般规格为200ml每瓶。针对上述目标人群,建议用量为:50-200ml每次,每天2次。最大剂量为:200ml每次,每天3次。
更进一步的,针对心火如焚、小便短赤、头痛目赤严重的情况,可酌情重用栀子,例如,加至20份。即,在一实施方案中,上述基础方和加强方中采用20份的栀子。
在本发明的又一实施方案中,重用芳香行气的原料,新会陈皮、广陈皮、青皮、枳壳、枳实可等比加至基础方(或加强方)的2-5倍,适用于脾胃呆滞、食少腹胀、胃肠动力差、痞满等情况。
在另一实施方案中,本发明还提供了在加强方基础上的适用于中度至重度的焦虑、惊恐、失眠多年患者的产品:一种可调理情绪的药食同源饮品,所述饮品按重量份计由以下原料制成:栀子1-20份、新会陈皮1-5份、广陈皮1-15份、青皮1-15份、枳壳1-20份、枳实1-10份、甘草1-20份、牡蛎20-50份、龙骨20-50份、灯心草3-5份、酸枣仁10-30份和柏子仁10-30份。短期服用好转后,再改为上述加强方。
儿童可酌量减少至每味药1份,加味灯心草1g,可治疗小儿夜啼。
本发明的产品中,栀子、橘皮类(新会陈皮、广陈皮、青皮、枳壳和枳实)、甘草和牡蛎四种中药也存录于国家规定的药食同源目录内,作为体检未见明显异常者、西药又无适应症状人群的食疗方剂。
其中,基础方中,主体以栀子、甘草、橘皮类、牡蛎等中草药组方,适用的治疗病症为:肝胃不和导致的嗳气、胃脘痛、吞酸嘈杂、呆食、抑郁、胃肠功能紊乱等症。情志内伤导致的焦虑、抑郁、惊恐、易怒、神经衰弱、神经官能症。心肾不交导致的心烦、烦热、失眠、惊悸、梦魇、耳鸣、盗汗等症。
含新会陈皮、广陈皮、青皮、枳壳和枳实这类芳香行气药(橘皮类)为君药,促进人体“气”的流转。其中青皮又能入肝,充当使药既为君药又为使药。在这一类原料中,首先选用名贵的新会陈皮,可以保证芳香行气的药效;同时,不全用新会陈皮(如,广陈皮),可以节省成本,并在行气这一功效上具有细微的“互补效果”:青皮作为使君药,使药效入肝经;此外,选用枳壳与枳实搭配,可以融合以上两位药性(在宽中下气上,枳壳缓、而枳实速也),使得适用人群更广。陈皮、青皮、枳壳、枳实虽同为行气药,但其细分功效又存在明显区别,而且在基础配比中,使用的总量为9g(份),较一般的处方的12g还小,是安全且有效的范围——用量少、行气效果“宽泛浑厚”、具有更大的普适性,因此更适宜作为药食同源的饮品产品。
栀子是臣药,一味清三焦热,最大的特点是本品与君药搭配,做清虚烦、除无名之火(抗焦虑)用。而,如上所述的,在心火如焚、小便短赤、头痛目赤严重的情况中,可将栀子调至最多20重量份,着重调理躯体热性症状。
甘草为佐助药,可调和药性,使之更加适应个体复杂情况。
牡蛎和龙骨,均可敛虚汗、治盗汗,取其收敛固涩、重镇安神之功效。
该方剂以栀子、甘草、橘皮、牡蛎等中药为主要成分,药食同源,组方逻辑清晰,对肝胃不和导致的嗳气、胃脘痛、吞酸嘈杂、呆食、抑郁、胃肠功能紊乱;情志内伤导致的焦虑、抑郁、惊恐、易怒、神经衰弱、神经官能症、植物神经功能紊乱;心肾不交导致的心烦、烦热、失眠、惊悸、梦魇、耳鸣、盗汗等诸多症状都有明显疗效。
酸枣仁和柏子仁,养心安神。灯心草可以增强清心火的作用。各进一步的原料按照针对症状的区别,分别选材配比,通过清心火、安神的作用,进一步调理心烦失眠的问题。
第二组加强方剂除疏肝理气、清虚烦外,增加了清心火、重镇安神、养心安神成分,对情绪障碍引起的上火、惊恐、失眠等身体症状有了较好的控制。
具体实施方式
为了使本发明要解决的技术问题、技术方案及有益效果更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
实施例一
具体按下述配比称取原料:
基础组方:栀子3g、新会陈皮1g、广陈皮2g、青皮3g、枳壳2g、枳实1g、甘草5g和牡蛎5g,经过中药传统熬制办法灌装而成。规格:200ml每瓶(袋)。
制备方法:称取上述原料后混合,加入660ml纯净水,浸泡30分钟,大火熬制沸腾,转小火再煎10分钟,熄火放置适宜温度即可饮用(剩余大约350-400ml,分早晚2次饮用)。
实施例二
具体按下述配比称取原料:
加强方:栀子3g、新会陈皮1g、广陈皮2g、青皮3g、枳壳2g、枳实1g、甘草7g、牡蛎20份、灯心草3g、酸枣仁10g、柏子仁10g和龙骨20g,经过中药传统熬制办法灌装而成。规格:200ml每瓶(袋)。
制备方法:称取上述原料后混合,加入1440ml纯净水,浸泡30分钟,大火熬制沸腾,转小火再煎10分钟,熄火放置适宜温度即可饮用(剩余大约850-1000ml,每次200ml,分早晚2次饮用)。
实施例三
除烦基础方:与实施例一的产品的原料、制法相同,区别为栀子用量为20g。
实施例四
除烦加强方:与实施例二的产品的原料、制法相同,区别为栀子用量为20g。
实施例五
脾胃基础方:与实施例一的产品的原料、制法相同,区别为:橘皮类原料用量为实施例一中的5倍,分别为:新会陈皮5g、广陈皮10g、青皮15g、枳壳10g和枳实5g。
实施例六
脾胃加强方:与实施例二的产品的原料、制法相同,区别为:橘皮类原料用量为实施例二中的2倍,分别为:新会陈皮2g、广陈皮4g、青皮6g、枳壳4g和枳实2g。
实施例七
安神方:栀子3g、新会陈皮1g、广陈皮2g、青皮3g、枳壳2g、枳实1g、甘草5g、牡蛎50g、龙骨20g、灯心草5g、酸枣仁30g和柏子仁30g,经过中药传统熬制办法灌装而成。规格:200ml每瓶(袋)。
制备方法:称取上述原料后混合,加入纯净水(20倍重量),浸泡30分钟,大火熬制沸腾,转小火再煎10分钟,熄火放置适宜温度即可饮用(分早晚2次饮用)。
上述方剂组合(实施例一至实施例七)已在程光照中医师创办的中医诊所、中医门诊部、涿州范阳中医医院中试验应用20余年,应用人次约1.5万人次。
其中人员组成为:性别不限,年龄自10岁至90岁,症状见焦虑、惊恐、心烦、失眠、情绪低落、抑郁等。
测试手段:以符合给予黛力新(氟哌噻吨美利曲辛)的症状标准,作为黛力新片的替代品作为实验,选取短期(5年内的年轻人)和长期轻、中度抑郁和焦虑症状的患者。给予实施例一或实施例二的产品7-21天,基本可缓解患者的抑郁和焦虑情绪。该结果已于20年内多次反复验证。
在此,总结其中1000人的数据,根据胃肠症状、情志表现明显和心肾不交三种突出/典型表现进行状况改善的总结(一名受试者可能存在两种或以上突出症状),结果如下表1中所示:
表1.实施例一和实施例二产品对于各症状的改善情况(14天为一周期)。
在上表1中,仅就更为“普适”的实施例一和实施例二的产品进行了效果总结/统计。而在实际应用过程中,根据除烦、脾胃症或安神需求更为突出、个别症状更具偏重的加重型受试者,一般建议首先施用一周期(或半周期)的特色方(如重用栀子的除烦方——实施例三或四),随后再施用普适方(实施例一或二),这样,第一周期的有效率(改善率)可普遍较上表中所示数据提高约2%。
此外,毒性测试:曾有一患者(男,60岁)取10天药物(实施例一产品,约4000ml)2天内喝完,未有明显不适。经这些年来的持续试验证实,本发明的产品由于原料均为药食同源材料,经制备提取后,作为饮品在较长时间(如,1-3个月)内持续定量饮用并不会带来亚健康人群的进一步的身体损伤,相反,通过针对性的芳香行气、清虚除烦的调理,为绝大多数(95%以上)由于情绪引起的不适的亚健康人群提供身体、心理和精神上的明显改善。
在此,再列出部分典型病例的具体情况(病史、诊断过程和服用情况、以及改善结果),其中,部分受试者由于综合服药,则未计入上表1的统计数据中。
典型重症病例1:张某某,女,55岁,2010年前后,因呕吐不能进食就诊,诉于保定市第二中心医院住院2月余,未见好转,仅靠肠外营养药物维持生命,遂来就诊。
诊断:肝胃不和证。中医认为肝主疏泄,喜调达而恶抑郁,肝通过其疏泄功能对气机的调畅作用,可调节人的精神情志活动,因而肝主情志。患者长期抑郁情绪、悲观、失落,阻碍肝脏疏泄功能,肝气疏泄受阻,肝属木,木克脾土,因而临床最常见的肝气疏泄受阻出现的症状就是肝气横逆,克制脾胃运化之气,出现胀满、嗝逆、反流等,临床上常见的反流性食管炎、反流性咽炎等都是这个原理。本例患者出现胃不受纳、吃一口吐一口的情况,就是典型的长期抑郁影响肝气因而侵犯脾胃导致脾胃受纳下降的气机失调,而出现气逆,通过哕呕的方式表现出来。
给予实施例一产品,先用小口多次饮用的方式(200ml药品完全服下长达2小时),每天2袋,取得了7天后可服下流食,20余天后可正常饮食的疗效。患者体重也在2年时间内,由不到40公斤涨到了60公斤。患者至今仍不时饮用本品以巩固疗效。
典型病例2:张某,女,42岁,2022年8月3日因情志不舒、郁郁寡欢、不思饮食来诊,询近期压力大,面对家庭、工作力不从心,给予实施例一产品,两周(一周期)后已有明显改善(食欲恢复,积极面对家庭事业中的困难,自述日渐开朗,焦虑减轻)。
典型案例3:姚某某,男,45岁。2004年夏季左右,因心慌、焦虑、心脏神经官能、头痛症既往病史就诊,给予实施例一产品,当下即服,5分钟见效。此后多次病发,打车来诊室,均当下即服后5分钟内上述症状消失。
典型病例4:刘某某,女,60岁,2022年7月17日,因慢性胃炎、慢性肠炎、抑郁、心境低落就诊,曾诊断抑郁障碍,辩为心肾不交证,给予实施例二产品+舒必利+安坦治疗10天,再访好转。
典型病例5:姜某某,女,55岁,2022年6月24日来诊,诉失眠多年,伴有反复心烦易怒、头晕目眩等(无高血压),最近加重,小便黄赤,脉沉细,辩为心血不足证,给予实施例一产品,加氯硝西泮片加强治疗顽固失眠,2周期后好转。
典型病例6:阮某某,女,40岁,2022年6月12日来诊,诉近期失眠健忘、头晕耳鸣、烦乱身躁、心跳偏快、心悸不安,辩为心肾不交证,给予实施例一产品,加服普萘洛尔保护心脏,1周期后好转。
典型病例7:平某某,女17岁,2022年6月12日家人送医,诉情绪低落、思维迟缓、行动乏力、失眠呆滞、社交回避、生活意向减退,不能回校学习,辩为肝气郁结证(抑郁症),给予实施例一产品+劳拉西泮,1周期后症状好转。
典型病例8:吴某某,女,56岁,2022年6月2日来诊,诉易醒难眠、双胁胀满、心烦易怒、胃失和降、吞酸纳呆、食不甘味。辩为肝胃不和证,给予实施例一产品+舒必利+安坦+氯硝西泮,疏肝安神,2周期后好转。
典型病例9:姚某某,女,53岁,2022年6月1日来诊,诉易怒烦躁、注意力下降、双胁胀痛、吞酸打嗝、脉弦细,给予实施例二产品,1周期好转。
典型病例10:王某某,女61岁,2022年3月4日来诊,诉焦虑恐惧、社交回避、怕光怕声、咽部不适、小便频数、顽固失眠、胆小惊慌等多年,现给予实施例二产品加舒必利、安坦、氯硝西泮以行气清躁、定心安神。3周期好转。
典型病例11:杨某某,女54岁,2022年3月23日来诊,诉头晕目眩、心情不畅、顽固失眠,辩为心血不足证,给予实施例一产品+舒必利+劳拉西泮给予定心安神,行气解郁治疗,1周期好转。
典型病例12:程某某,男15岁,诉咳嗽黄痰(核酸排除新冠)、头痛难忍、彻夜难眠3天,给予葛根素解痉止痛、利福平抗炎、异丙嗪止敏平喘、实施例一产品行气、调理三焦促进康复。
上述实施例只是为了说明本发明的技术构思及特点,其目的是在于让本领域内的普通技术人员能够了解本发明的内容并据以实施,并不能以此限制本发明的保护范围。凡是根据本发明内容的实质所作出的等效的变化或修饰,都应涵盖在本发明的保护范围内。
Claims (10)
1.一种可调理情绪的药食同源饮品,其特征在于,所述饮品按重量份计由以下原料制成:栀子1-20份、新会陈皮1-5份、广陈皮1-15份、青皮1-15份、枳壳1-20份、枳实1-10份、甘草1-20份和牡蛎1-50份。
2.根据权利要求1所述的可调理情绪的药食同源饮品,其特征在于,所述饮品按重量份计由以下原料制成:栀子3份、新会陈皮1份、广陈皮2份、青皮3份、枳壳2份、枳实1份、甘草5份和牡蛎5份。
3.根据权利要求1或2所述的可调理情绪的药食同源饮品,其特征在于,所述饮品通过如下方法制备:按重量份比例称取栀子、新会陈皮、广陈皮、青皮、枳壳、枳实、甘草和牡蛎;混合均匀,加入原料总重量的20-30倍重量的水,浸泡30分钟;将浸泡后的混合物大火熬制至沸腾,转小火再煎10分钟;熄火,冷却至室温,即获得所述饮品。
4.一种可调理情绪的药食同源饮品,其特征在于,所述饮品按重量份计由以下原料制成:栀子1-20份、新会陈皮1-5份、广陈皮1-15份、青皮1-15份、枳壳1-20份、枳实1-10份、甘草1-20份、牡蛎1-50份、龙骨1-50份、灯心草1-10份、酸枣仁1-30份和柏子仁1-30份。
5.根据权利要求4所述的可调理情绪的药食同源饮品,其特征在于,所述饮品按重量份计由以下原料制成:栀子3份、新会陈皮1份、广陈皮2份、青皮3份、枳壳2份、枳实1份、甘草7份、灯心草3份、酸枣仁10份、柏子仁10份、龙骨20份和牡蛎20份。
6.根据权利要求4或5所述的可调理情绪的药食同源饮品,其特征在于,所述饮品通过如下方法制备:按重量份比例称取栀子、新会陈皮、广陈皮、青皮、枳壳、枳实、甘草、灯心草、酸枣仁、柏子仁、龙骨和牡蛎;混合均匀,加入原料总重量的20-30倍重量的水,浸泡30分钟;将浸泡后的混合物大火熬制至沸腾,转小火再煎10分钟;熄火,冷却至室温,即获得所述饮品。
7.根据权利要求2或5所述的可调理情绪的药食同源饮品,其特征在于,其中的栀子的量为20重量份。
8.根据权利要求2或5所述的可调理情绪的药食同源饮品,其特征在于,其中的新会陈皮、广陈皮、青皮、枳壳和枳实的用量可提高至2-5倍的量。
9.一种可调理情绪的药食同源饮品,其特征在于,所述饮品按重量份计由以下原料制成:栀子1-20份、新会陈皮1-5份、广陈皮1-15份、青皮1-15份、枳壳1-20份、枳实1-10份、甘草1-20份、牡蛎20-50份、龙骨20-50份、灯心草3-5份、酸枣仁10-30份和柏子仁10-30份。
10.根据权利要求1-9任一所述的可调理情绪的药食同源饮品,其特征在于,所述饮品的用量为50-200ml每次,每天2次。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211132799.0A CN116076637A (zh) | 2022-09-15 | 2022-09-15 | 一种可调理情绪的药食同源饮品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211132799.0A CN116076637A (zh) | 2022-09-15 | 2022-09-15 | 一种可调理情绪的药食同源饮品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116076637A true CN116076637A (zh) | 2023-05-09 |
Family
ID=86205224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211132799.0A Pending CN116076637A (zh) | 2022-09-15 | 2022-09-15 | 一种可调理情绪的药食同源饮品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116076637A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079350A (zh) * | 2014-05-18 | 2015-11-25 | 李琰 | 治疗失眠症的中药组合物 |
CN105617069A (zh) * | 2014-11-05 | 2016-06-01 | 浙江海洋学院 | 一种用于调节双相情感障碍疾病的口服液及其制备方法 |
CN108159352A (zh) * | 2018-02-06 | 2018-06-15 | 赵子荣 | 一种疏肝解郁的药物 |
CN110201076A (zh) * | 2018-02-28 | 2019-09-06 | 刘大兵 | 胸椎胸背经络活血药剂 |
-
2022
- 2022-09-15 CN CN202211132799.0A patent/CN116076637A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079350A (zh) * | 2014-05-18 | 2015-11-25 | 李琰 | 治疗失眠症的中药组合物 |
CN105617069A (zh) * | 2014-11-05 | 2016-06-01 | 浙江海洋学院 | 一种用于调节双相情感障碍疾病的口服液及其制备方法 |
CN108159352A (zh) * | 2018-02-06 | 2018-06-15 | 赵子荣 | 一种疏肝解郁的药物 |
CN110201076A (zh) * | 2018-02-28 | 2019-09-06 | 刘大兵 | 胸椎胸背经络活血药剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115501305B (zh) | 治疗肝郁脾虚湿盛型抑郁症的中药组合物及其用途 | |
CN1292792C (zh) | 一种治疗抑郁症的中药药物 | |
CN112190638A (zh) | 一种治疗脑梗死恢复期卒中后失眠的中药组合物及其应用 | |
CN105535412A (zh) | 一种补肾健脑中草药 | |
CN111249355A (zh) | 一种预防和/或治疗失眠的中药穴位敷贴及其应用 | |
CN104524416A (zh) | 一种药物组合物、用途、制备方法及由其制得的药物、食品和/或保健品 | |
CN103948708B (zh) | 一种治疗不安腿综合征的中药 | |
CN110604783A (zh) | 一种治疗失眠的中药组合物饮品及其制备方法 | |
CN110279797A (zh) | 一种抑郁症防治用中药茶饮 | |
CN116076637A (zh) | 一种可调理情绪的药食同源饮品 | |
CN109646526A (zh) | 一种用于治疗抑郁症的中药组合物及其制备方法 | |
CN101543587A (zh) | 用以治疗多发性抽动症的中草药复方及应用其药学组成物 | |
CN105727204A (zh) | 一种用于治疗躁狂症的药物制剂及其用途 | |
CN103251833A (zh) | 一种治疗失眠型贲门炎的中药制备方法 | |
CN103961578A (zh) | 一种治疗神经衰弱的中药药酒 | |
CN104189694B (zh) | 一种含益智仁和枸杞的中药组合物及其制备方法 | |
CN104306933B (zh) | 一种治疗抑郁症的中药组合物 | |
CN105920409A (zh) | 一种用于治疗阿尔茨海默病的药物制剂及其用途 | |
CN102784357B (zh) | 一种治疗嗜饮浓茶型失眠的中药制备方法 | |
CN106692757A (zh) | 治疗失眠的中成药 | |
CN106139035B (zh) | 治疗脑萎缩、老年痴呆及脑梗塞的中药及其制备和应用 | |
CN105343567B (zh) | 小儿安睡方 | |
CN105194049A (zh) | 一种用于治疗内科神经症患者的中药 | |
CN105250650A (zh) | 一种治疗功能性呕吐的中药制剂 | |
CN105434976B (zh) | 一种抗疲劳的中药复合物、其制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |